Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against Prestige Consumer Healthcare Inc.. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Prestige Consumer Healthcare Inc. (“Prestige” or “the Company”) (NYSE: PBH). Investors who purchased Prestige securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether Prestige has violated federal securities laws.
Prestige Investigation Details
On May 13, 2026, Prestige announced fourth quarter and full year 2026 earnings, disclosing that “for fiscal ‘26, revenues decreased 4.5% organically versus the prior year” and “[t]otal company adjusted gross margin of 55.6% for the year was approximately flat to 55.8% in the prior year.” In the associated earnings call, the Company’s CEO Ron Lombardi revealed that “in Q4, Clear Eyes sales were below expectations due to delayed shipments and production shutdowns ahead of line updates.” Following this news, Prestige’s stock price fell $5.88 per share, or 11.35%, to close at $45.93 per share on May 14, 2026.
What’s Next for Prestige Investors?
If you are aware of any facts relating to this investigation or purchased Prestige securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
PBH — Stock Performance
About Bronstein, Gewirtz & Grossman, LLC
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”